Q: How is the pace and quality of enrollment in Asia compared to the US? A: The pace of enrollment in Asia is about 2 to 4 times faster than in the US. The sites in Asia ramped up faster, and in the past few months, the output from Asia has matched that of the
Research and Development Expenses (Q4 2024): $6 million, up from $4 million in Q4 2023. Research and Development Expenses (Full-Year 2024): $19.4 million, up from $16.5 million in 2023. Net Loss (Q4 2024): $12.1 million, compared to $6.7 million in Q4 2023. Net Loss (Full-Year 2024): $62.3 million, compared to $27.0 million in 2023. Stock
Net Loss: $11.4 million for Q4 2024, compared to $7.8 million in Q4 2023. R&D Expenses: $9.3 million in Q4 2024, up from $6.5 million in Q4 2023. G&A Expenses: $2.9 million in Q4 2024, compared to $2.4 million in Q4 2023. Cash, Cash Equivalents, and Marketable Securities: $107.6 million as of December 31, 2024.
Revenue: $5.9 million in Q4 2024, down from $6.7 million in Q4 2023. Operating Loss: $1.3 million in Q4 2024, compared to operating income of $0.1 million in Q4 2023. Net Loss: $1 million or $0.07 per share in Q4 2024, versus net income of $0.2 million or $0.01 per diluted share in Q4 2023.
Cash, Cash Equivalents, and Marketable Securities: $134.6 million at the end of 2024. Net Cash Used in Operating Activities: $19.3 million for Q4 2024, down from $32 million in Q4 2023. Collaboration Revenue: $16.4 million for Q4 2024, up from $10.7 million in Q4 2023. Research & Development Expenses: $22.3 million for Q4 2024, compared
Net Pyrukynd Revenue (Q4 2024): $10.7 million, a 51% increase from $7.1 million in Q4 2023. Cost of Sales (Q4 2024): $1.3 million. R&D Expenses (Q4 2024): $82.8 million, an increase of $5.3 million from Q4 2023. SG&A Expenses (Q4 2024): $51.7 million, an increase of $16.4 million from Q4 2023. Cash Equivalents and Marketable
Earnings Per Share (EPS): $1.28 per diluted share for Q4 2024, compared to $1.32 in the previous quarter and $1.16 in Q4 2023. Adjusted Return on Assets: 1.31% for Q4 2024. Pre-Provision Return on Assets: 1.80% for Q4 2024. Net Interest Margin: Remained above 4% and was essentially flat compared to the previous quarter. Loan